Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TranspoCART19 in Refractory Lupus Nephritis
NCT07799116Phase 2Recruiting
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 2 trial of TranspoCART19 in lupus nephritis (LN), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Started Sep 2026; status: recruiting.
02
Drugs
TranspoCART19
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT07799116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07799116.